What question did this study set out to answer?

This research aims to develop a multi-agent architecture that models complex biological behaviors and improves predictions of immunotherapy outcomes.

August 6, 2026Open Access

Non-Markovian Trajectory Modeling in Multi-Agent Biological Information Systems

View Full Paper

Ask AI

Bookmark

Authors

Randomized trial demonstrates improved prediction of immunotherapeutic resistance in NSCLC models, implying advanced modeling accuracy.

This research aims to develop a multi-agent architecture that models complex biological behaviors and improves predictions of immunotherapy outcomes.
Introduced a state-space architecture using the Bio-Stochastic Continuum (BSC) Engine.
Employing Non-Parametric Bayesian Swarms for dynamic probability distribution calculations.
Testing with a synthetic cohort of 10,000 non-small cell lung cancer profiles.
Successfully predicted immunotherapeutic resistance pathways an average of 22 days earlier than traditional biomarkers.
Maintained 100% uptime under a 400% stress surge with < 45 ms processing latency.
Achieved an 84% reduction in clinical data ingestion friction and a 41% reduction in compute expenditure.

David L. Mincey (2026) studied this question.

View Full Paper

Ask AI

Bookmark